Cancer Support Group

Tuesday, Apr 20th

Last update:06:42:40 AM GMT

Year 2013

Cadila Launches Low-cost Cancer Drug

Cadila Pharmaceuticals introduced the first novel product for cancer management which it claims is a significant breakthrough in the treatment of lung cancer.

Mycidac–C is an innovative research product for patients suffering from a cancer sub–type – non–small cell lung cancer – and will be priced at Rs 4,000 for 10 injections. The total cost of therapy to patients is estimated at Rs 40,000 – which the company claims is affordable as cancer treatment is generally exorbitant.


Page 3 of 32


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo